Publication
The effect of 5‐azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes
Panagiotis T. Diamantopoulos, Argiris Symeonidis, Vasiliki Pappa, Ioannis Kotsianidis, Athanasios Galanopoulos, Charalampos Pontikoglou, Achilles Anagnostopoulos, George Vassilopoulos, Panagiotis Zikos, Eleftheria Hatzimichael, Maria Papaioannou, Aekaterini Megalakaki, Panagiotis Repousis, Maria Kotsopoulou, Maria Dimou, Elena Solomou, Georgios Dryllis, Dimitrios Tsokanas, Menelaos‐Konstantinos Papoutselis, Sotirios Papageorgiou, Marie‐Christine Kyrtshonis, Alexandra Kourakli, Helen Papadaki, Panayiotis Panayiotidis, Nora‐Athina Viniou
British Journal of Haematology, August 2020, Wiley
DOI: 10.1111/bjh.17062